COVID-19-associated brief psychotic disorder

Area of Science:

• Neuroscience
• Infectious Diseases
• Psychiatry

Background:

• COVID-19 is a global pandemic with diverse clinical manifestations.
• Neuropsychiatric symptoms have been reported in some COVID-19 patients.
• The potential for severe mental illness in individuals without prior psychiatric history is an emerging concern.

Observation:

• A 36-year-old woman with no prior mental health history presented with new-onset psychosis.
• The psychosis emerged concurrently with symptomatic COVID-19 infection.
• Psychotic symptoms showed improvement with standard psychiatric medications and resolution of the viral illness.

Findings:

• This case represents the first documented instance of COVID-19-associated psychosis in an individual with no personal or family history of severe mood or psychotic disorders.
• The temporal association suggests a potential causal link between COVID-19 infection and the development of psychosis.
• The patient's recovery correlated with the clearance of COVID-19 symptoms.

Implications:

• Clinicians should maintain a high index of suspicion for neuropsychiatric complications in patients with COVID-19, even in the absence of pre-existing mental health conditions.
• Vigilant monitoring for psychosis and other neurological or psychiatric symptoms is crucial in individuals diagnosed with COVID-19.
• Further research is warranted to elucidate the mechanisms underlying COVID-19-associated psychosis and to develop targeted treatment strategies.